Description
Physical Appearance: Fine white lyophilized powder
Contents: 5 mg Tesamorelin per vial
Peptide Purity: >99%
Stability:
- Lyophilized: Store at -20°C
- Reconstituted: Store at 4°C and avoid repeated freeze-thaw cycles
Chemical Profile
Chemical Name: Tesamorelin Acetate
Molecular Formula: C₂₂₃H₃₇₀N₇₂O₆₉S
Molecular Weight: 5135.96 g/mol
Peptide Sequence:
Unk-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂ • CH₃CO₂H
Class: GHRH Analog (Growth Hormone-Releasing Hormone)
Half-Life: ~20–30 minutes (GH secretion duration: ~2 hours)
About Tesamorelin
Tesamorelin is a stabilized analog of growth hormone-releasing hormone (GHRH) that has been modified to increase resistance to enzymatic degradation and enhance half-life. It promotes the pituitary release of endogenous growth hormone, resulting in downstream increases in IGF-1. Research has shown Tesamorelin to be effective in reducing visceral fat and improving lipid profiles, particularly in metabolic and aging-related studies.
Research Studies
▪ Endogenous Growth Hormone Stimulation
▪ Visceral Fat Reduction
- Shown to selectively reduce VAT (visceral adipose tissue)
- Researched in HIV-associated lipodystrophy and metabolic syndrome
▪ Cognitive & Metabolic Health
- Preliminary research supports benefits in memory, cognition, and lipid modulation
- Studied for potential neuroprotective and anti-aging effects
Disclaimer
Tesamorelin is offered strictly for laboratory research use only. It is not approved for human or veterinary use and must be handled solely by licensed professionals in controlled research environments.
